Enterprise Value
7.334B
Cash
2.215B
Avg Qtr Burn
-80.86M
Short % of Float
6.47%
Insider Ownership
0.83%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
QALSODY™ (Tofersen) Details Amyotrophic lateral sclerosis | Approved Update | |
WAINUA™ Eplontersen (AKCEA-TTR-LRx) Details Transthyretin amyloidosis | Approved Quarterly sales | |
SPINRAZA Details Spinal muscular atrophy | Approved Quarterly sales | |
IONIS-APOCIII-LRx (Olezarsen) Details Familial chylomicronemia syndrome | PDUFA Approval decision | |
Donidalorsen (IONIS-PKK-LRx) Details Hereditary angioedema | NDA Submission | |
Bepirovirsen (IONIS-HBVRx) Details Hepatitis B | Phase 3 Data readout | |
Ulefnersen (ION363 ) Details Amyotrophic lateral sclerosis | Phase 3 Data readout | |
Zilganersen (ION373) Details Alexander Disease | Phase 3 Data readout | |
IONIS-APOCIII-LRx (Olezarsen) Details Severe hypertriglyceridemia | Phase 3 Data readout | |
Pelacarsen Details Heart disease, Cardiovascular disease | Phase 3 Data readout | |
Eplontersen (AKCEA-TTR-LRx) Details Diabetic cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Transthyretin amyloidosis | Phase 3 Data readout | |
IONIS-FB-LRx Details IgA nephropathy | Phase 3 Initiation | |
ION582 Details Angelman Syndrome | Phase 3 Initiation | |
ION839 / AZD2693 Details Non-alcoholic steatohepatitis | Phase 2b Data readout | |
ION224 Details Non-alcoholic steatohepatitis | Phase 2b Update | |
IONIS-MAPTRx (BIIB080) Details Alzheimer's disease | Phase 2 Data readout | |
IONIS-FB-LRx Details Geographic atrophy | Phase 2 Data readout | |
Tominersen (IONIS-HTT Rx) Details Huntington's disease | Phase 2 Update | |
IONIS-AGT-LRx Details Heart failure, Pulmonary hypertension | Phase 2 Update | |
Cimdelirsen (IONIS-GHR-LRx) Details Acromegaly | Failed Discontinued | |
IONIS-ENaC-2.5Rx (antisense medicine) Details Cystic fibrosis | Failed Discontinued | |
Fesomersen (IONIS-FXI-LRx) Details Hepatitis B | Failed Discontinued |